» Articles » PMID: 29955160

Sample-to-Answer Droplet Magnetofluidic Platform for Point-of-Care Hepatitis C Viral Load Quantitation

Overview
Journal Sci Rep
Specialty Science
Date 2018 Jun 30
PMID 29955160
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Gold standard quantitative nucleic acid tests for diagnosis of viral diseases are currently limited to implementation in laboratories outside of the clinic. An instrument for conducting nucleic acid testing at the point-of-care (POC) that is easily operable by the clinician would reduce the required number of visits to the clinic and improve patient retention for proper treatment. Here we present a droplet magnetofluidic (DM) platform, which leverages functionalized magnetic particles to miniaturize and automate laboratory assays for use in the clinic at the POC. Our novel thermoformed disposable cartridge coupled to a portable multiaxial magnetofluidic instrument enables real-time PCR assays for quantitative and sensitive detection of nucleic acids from crude biosamples. Instead of laborious benchtop sample purification techniques followed by elution and spiking into PCR buffer, the user simply injects the biosample of interest into a cartridge with magnetic particles and loads the cartridge into the instrument. We demonstrate the utility of our platform with hepatitis C virus (HCV) RNA viral load quantitation from blood serum in approximately 1 hour. Clinical serum samples (n = 18) were directly processed on cartridges with no false positives and a limit of detection of 45 IU per 10 µl sample injection.

Citing Articles

Saliva-STAT: Sample-to-answer saliva test for COVID-19.

Boegner D, Rzasa J, Benke E, White I Sens Actuators B Chem. 2024; 421.

PMID: 39282013 PMC: 11391883. DOI: 10.1016/j.snb.2024.136510.


Sample-to-Answer Detection of SARS-CoV-2 Viremia Using Thermally Responsive Alkane Partitions.

Boegner D, Na M, Harris A, Christenson R, Damcott C, King B Anal Chem. 2024; 96(29):12049-12056.

PMID: 38975928 PMC: 11724521. DOI: 10.1021/acs.analchem.4c02105.


Prospects of Microfluidic Technology in Nucleic Acid Detection Approaches.

Mumtaz Z, Rashid Z, Ali A, Arif A, Ameen F, AlTami M Biosensors (Basel). 2023; 13(6).

PMID: 37366949 PMC: 10296372. DOI: 10.3390/bios13060584.


Advances in point-of-care genetic testing for personalized medicine applications.

de Olazarra A, Wang S Biomicrofluidics. 2023; 17(3):031501.

PMID: 37159750 PMC: 10163839. DOI: 10.1063/5.0143311.


Rapid on-site nucleic acid testing: On-chip sample preparation, amplification, and detection, and their integration into all-in-one systems.

Wang J, Jiang H, Pan L, Gu X, Xiao C, Liu P Front Bioeng Biotechnol. 2023; 11:1020430.

PMID: 36815884 PMC: 9930993. DOI: 10.3389/fbioe.2023.1020430.


References
1.
Falade-Nwulia O, Mehta S, Lasola J, Latkin C, Niculescu A, OConnor C . Public health clinic-based hepatitis C testing and linkage to care in Baltimore. J Viral Hepat. 2016; 23(5):366-74. PMC: 4836954. DOI: 10.1111/jvh.12507. View

2.
Pawlotsky J, Bouvier-Alias M, Hezode C, Darthuy F, Remire J, Dhumeaux D . Standardization of hepatitis C virus RNA quantification. Hepatology. 2000; 32(3):654-9. DOI: 10.1053/jhep.2000.16603. View

3.
Zhang Y, Park S, Liu K, Tsuan J, Yang S, Wang T . A surface topography assisted droplet manipulation platform for biomarker detection and pathogen identification. Lab Chip. 2010; 11(3):398-406. PMC: 4626018. DOI: 10.1039/c0lc00296h. View

4.
Mirmajlessi S, Destefanis M, Gottsberger R, Mand M, Loit E . PCR-based specific techniques used for detecting the most important pathogens on strawberry: a systematic review. Syst Rev. 2015; 4:9. PMC: 4320524. DOI: 10.1186/2046-4053-4-9. View

5.
Edlin B, Eckhardt B, Shu M, Holmberg S, Swan T . Toward a more accurate estimate of the prevalence of hepatitis C in the United States. Hepatology. 2015; 62(5):1353-63. PMC: 4751870. DOI: 10.1002/hep.27978. View